Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
This is a crisis scenario that defines a CEO's legacy. The decision matrix is clear: Patient safety and regulatory compliance must supersede short-term financial protection. Hiding this information constitutes securities fraud and potential criminal negligence (precedents include Vioxx/Merck and Purdue Pharma).Read the full answer